Talphera (TLPH) Stock: Buy, Sell, or Hold?
TLPH - Talphera, Inc. Common Stock
$1.24
0.00 (0.00%)
▲
5d:
+3.33%
30d:
-11.43%
90d:
+49.4%
BUY
HIGH Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When TLPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TLPH shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: TLPH shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: TLPH is currently trading at $1.24, which is considered fair relative to its 30-day fair value range of $1.17 to $1.34.
Technical Outlook: Technically, TLPH is in a strong uptrend. The price is approaching resistance at $1.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TLPH scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.17 (+155.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TLPH is in a strong uptrend. The price is approaching resistance at $1.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TLPH scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.17 (+155.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.17 -
$1.34
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (80/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 155.4% below Wall St target ($3.17)
- BULLISH: Bottoming setup score 80/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.17 -
$1.34
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.17
Resistance Level
$1.26
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.06
Wall Street Target
$3.17
(+155.4%)
Share & Embed Analysis
Last updated: September 13, 2026 10:40 AM ET
Data refreshes hourly during market hours. Next update: 11:40 AM
Data refreshes hourly during market hours. Next update: 11:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 70 BUY |
|
INDV
Indivior PLC Ordinary Sh… |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 46 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 47 HOLD |
